Changes in liver steatosis after switching from efavirenz to raltegravir among human immunodeficiency virus-infected patients with nonalcoholic fatty liver disease

  1. Macías, J.
  2. Mancebo, M.
  3. Merino, D.
  4. Téllez, F.
  5. Montes-Ramírez, M.L.
  6. Pulido, F.
  7. Rivero-Juárez, A.
  8. Raffo, M.
  9. Pérez-Pérez, M.
  10. Merchante, N.
  11. Cotarelo, M.
  12. Pineda, J.A.
Revue:
Clinical Infectious Diseases

ISSN: 1537-6591,  1058-4838

Année de publication: 2017

Volumen: 65

Número: 6

Pages: 1012-1019

Type: Article

DOI: 10.1093/CID/CIX467 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus